# Single Ascending Dose Study of CM326 in Healthy Volunteers

> **NCT04842201** · PHASE1 · COMPLETED · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 44 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CM326
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04842201
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-13
- **Primary completion:** 2021-09-28
- **Final completion:** 2021-09-28
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04842201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04842201, "Single Ascending Dose Study of CM326 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04842201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*